Antimicrobial resistance (AMR) is a major global concern. The overuse and misuse of antimicrobials in both humans and animals are the leading drivers of AMR . To date, there have been three surveys on Healthcare-Associated Infections in Long-Term Care Facilities (HALT) in the European Union (EU)/European Economic Area (EEA) (2010, 2013 and 2016/17), coordinated by the European Centre for Disease Prevention and Control (ECDC) [2–4]. The second EU/EEA point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in long-term care facilities (LTCFs), performed in 2013, reported a crude European prevalence of residents on antimicrobials in LTCFs of 4%, ranging from 1% in Hungary to 12% in Greece . In Ireland, the figure was 9.8% and on any given day, residents in Irish LTCFs were twice as likely to receive an antimicrobial compared with the EU/EEA average . A considerable proportion (28%) of antimicrobial use in LTCFs in EU/EEA region was prophylactic [2,3]. In Ireland, the figure was even higher, at 38% .
Citation style for this article: Euro Surveill. 2019;24(11):pii=1800102. https://doi.org/10.2807/1560-7917.ES.2019.24.11.1800102. A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016.